DermACELL Acellular Dermal Matrix in Oncologic Breast Reconstruction: A Cohort Study and Systematic Review

Background:. Acellular dermal matrices (ADMs) are commonly used in tissue expander and direct-to-implant reconstruction following mastectomy. Few studies have reported outcomes of DermACELL use or compared DermACELL with AlloDerm ADM. This study sought to compare outcomes of DermACELL and AlloDerm i...

Full description

Bibliographic Details
Main Authors: Austin R. Swisher, BS, Mark J. Landau, MD, PhD, Nikita Kadakia, MD, Stephanie W. Holzmer, MD, Hahns Y. Kim, MD
Format: Article
Language:English
Published: Wolters Kluwer 2022-06-01
Series:Plastic and Reconstructive Surgery, Global Open
Online Access:http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000004396
_version_ 1811332754261934080
author Austin R. Swisher, BS
Mark J. Landau, MD, PhD
Nikita Kadakia, MD
Stephanie W. Holzmer, MD
Hahns Y. Kim, MD
author_facet Austin R. Swisher, BS
Mark J. Landau, MD, PhD
Nikita Kadakia, MD
Stephanie W. Holzmer, MD
Hahns Y. Kim, MD
author_sort Austin R. Swisher, BS
collection DOAJ
description Background:. Acellular dermal matrices (ADMs) are commonly used in tissue expander and direct-to-implant reconstruction following mastectomy. Few studies have reported outcomes of DermACELL use or compared DermACELL with AlloDerm ADM. This study sought to compare outcomes of DermACELL and AlloDerm in oncologic breast reconstruction and to review the literature reporting outcomes of patients undergoing reconstruction using DermACELL. Methods:. We conducted a retrospective cohort study to compare outcomes between DermACELL and AlloDerm ADM, and a systematic review of the literature with a meta-analysis to evaluate clinical outcomes with DermACELL. Results:. Seventy-four patients (128 breasts) undergoing immediate reconstruction were evaluated retrospectively. Chi-square analysis revealed no significant difference in postoperative outcomes between the two groups. Our systematic review of the literature yielded 12 total studies reporting DermACELL use for breast reconstruction encompassing 518 patients and 608 total breasts. A pooled analysis of the published data did not reveal a significant change in the rate of explantation when either chemotherapy or radiation was used. Meta-analysis did not show a significant difference in the rate of any of the complications evaluated. Conclusion:. DermACELL is safe to use with a relatively consistent complication profile as compared with AlloDerm.
first_indexed 2024-04-13T16:41:44Z
format Article
id doaj.art-38420ab8a4dd4b1fa087d766adedadcb
institution Directory Open Access Journal
issn 2169-7574
language English
last_indexed 2024-04-13T16:41:44Z
publishDate 2022-06-01
publisher Wolters Kluwer
record_format Article
series Plastic and Reconstructive Surgery, Global Open
spelling doaj.art-38420ab8a4dd4b1fa087d766adedadcb2022-12-22T02:39:13ZengWolters KluwerPlastic and Reconstructive Surgery, Global Open2169-75742022-06-01106e439610.1097/GOX.0000000000004396202206000-00043DermACELL Acellular Dermal Matrix in Oncologic Breast Reconstruction: A Cohort Study and Systematic ReviewAustin R. Swisher, BS0Mark J. Landau, MD, PhD1Nikita Kadakia, MD2Stephanie W. Holzmer, MD3Hahns Y. Kim, MD4From the * Department of Surgery, University of California, Riverside School of Medicine, Riverside, Calif.† Department of Plastic Surgery, Loma Linda University, Loma Linda, Calif.† Department of Plastic Surgery, Loma Linda University, Loma Linda, Calif.† Department of Plastic Surgery, Loma Linda University, Loma Linda, Calif.† Department of Plastic Surgery, Loma Linda University, Loma Linda, Calif.Background:. Acellular dermal matrices (ADMs) are commonly used in tissue expander and direct-to-implant reconstruction following mastectomy. Few studies have reported outcomes of DermACELL use or compared DermACELL with AlloDerm ADM. This study sought to compare outcomes of DermACELL and AlloDerm in oncologic breast reconstruction and to review the literature reporting outcomes of patients undergoing reconstruction using DermACELL. Methods:. We conducted a retrospective cohort study to compare outcomes between DermACELL and AlloDerm ADM, and a systematic review of the literature with a meta-analysis to evaluate clinical outcomes with DermACELL. Results:. Seventy-four patients (128 breasts) undergoing immediate reconstruction were evaluated retrospectively. Chi-square analysis revealed no significant difference in postoperative outcomes between the two groups. Our systematic review of the literature yielded 12 total studies reporting DermACELL use for breast reconstruction encompassing 518 patients and 608 total breasts. A pooled analysis of the published data did not reveal a significant change in the rate of explantation when either chemotherapy or radiation was used. Meta-analysis did not show a significant difference in the rate of any of the complications evaluated. Conclusion:. DermACELL is safe to use with a relatively consistent complication profile as compared with AlloDerm.http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000004396
spellingShingle Austin R. Swisher, BS
Mark J. Landau, MD, PhD
Nikita Kadakia, MD
Stephanie W. Holzmer, MD
Hahns Y. Kim, MD
DermACELL Acellular Dermal Matrix in Oncologic Breast Reconstruction: A Cohort Study and Systematic Review
Plastic and Reconstructive Surgery, Global Open
title DermACELL Acellular Dermal Matrix in Oncologic Breast Reconstruction: A Cohort Study and Systematic Review
title_full DermACELL Acellular Dermal Matrix in Oncologic Breast Reconstruction: A Cohort Study and Systematic Review
title_fullStr DermACELL Acellular Dermal Matrix in Oncologic Breast Reconstruction: A Cohort Study and Systematic Review
title_full_unstemmed DermACELL Acellular Dermal Matrix in Oncologic Breast Reconstruction: A Cohort Study and Systematic Review
title_short DermACELL Acellular Dermal Matrix in Oncologic Breast Reconstruction: A Cohort Study and Systematic Review
title_sort dermacell acellular dermal matrix in oncologic breast reconstruction a cohort study and systematic review
url http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000004396
work_keys_str_mv AT austinrswisherbs dermacellacellulardermalmatrixinoncologicbreastreconstructionacohortstudyandsystematicreview
AT markjlandaumdphd dermacellacellulardermalmatrixinoncologicbreastreconstructionacohortstudyandsystematicreview
AT nikitakadakiamd dermacellacellulardermalmatrixinoncologicbreastreconstructionacohortstudyandsystematicreview
AT stephaniewholzmermd dermacellacellulardermalmatrixinoncologicbreastreconstructionacohortstudyandsystematicreview
AT hahnsykimmd dermacellacellulardermalmatrixinoncologicbreastreconstructionacohortstudyandsystematicreview